Chapter 341 |
2024 -- S 2609 SUBSTITUTE A Enacted 06/25/2024 |
A N A C T |
RELATING TO HEALTH AND SAFETY -- DENSE BREAST NOTIFICATION AND EDUCATION |
Introduced By: Senators Valverde, Lawson, Sosnowski, Gallo, Lauria, Murray, DiMario, Ujifusa, Quezada, and Euer |
Date Introduced: March 01, 2024 |
It is enacted by the General Assembly as follows: |
SECTION 1. Section 23-12.9-2 of the General Laws in Chapter 23-12.9 entitled "Dense |
Breast Notification and Education" is hereby amended to read as follows: |
23-12.9-2. Public policy goals — Department of health. |
The department of health, through the Rhode Island Cancer Council, is authorized and |
mandated to implement the following public health policy goals as they relate to dense breast |
notification in Rhode Island. Commencing on October 1, 2014, all All healthcare facilities that |
perform mammography examinations shall include in the summary of the mammography report to |
be provided to a patient by mail, electronically, or otherwise, information that identifies the |
patient’s individual Breast Tissue Classification based on the Breast Imaging Reporting and Data |
System established by the American College of Radiology. If the The facility determines that a |
patient has heterogeneously or extremely dense breasts, the summary of the mammography report |
shall also include the following mandated FDA National Reporting Standard for breast density |
patient notification language in the notice to the patient.: |
“Your mammogram indicates that you have dense breast tissue. Dense breast tissue is |
relatively common and is found in about forty percent (40%) of women. The presence of dense |
tissue can make it more difficult to detect cancers in the breast by mammography because it can |
hide small abnormalities and may be associated with an increased risk. Hence, you may benefit |
from supplementary screening tests, which may include a breast ultrasound screening, or a breast |
MRI examination, or both, depending on your individual risk factors. |
We are providing this information to raise your awareness of this important factor and to |
encourage you to discuss your dense breast tissue, as well as other breast cancer risk factors, with |
your healthcare provider. Together, you can decide which screening options are right for you. |
A report of your results was sent to your physician. You should contact your physician if |
you have any questions or concerns about this report.” |
SECTION 2. This act shall take effect upon passage. |
======== |
LC005338/SUB A |
======== |